Electroconvulsive therapy for persistent neuroleptic-induced akathisia and parkinsonism: a case report.
Neuroleptic-induced akathisia (NIA) and parkinsonism (NIP) continued for 3 months, despite two courses of anticholinergic treatments, a shift to low-potent neuroleptic (NL) and a NL-free period. The two adverse effects responded dramatically to electroconvulsive therapy (ECT) to reemerge 3 months after termination of ECT. The case supports the idea that ECT is effective for both NIA and NIP even when they are resistant.
Geha Psychiatric Hospital, Beilinson Medical Center, Petah Tikva, Israel.
H
H
Hermesh
D
D
Aizenberg
G
G
Friedberg
M
M
Lapidot
H
H
Munitz
D000328:Adult; D017109:Akathisia, Drug-Induced; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D009460:Neurologic Examination; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000628:therapy; D011595:Psychomotor Agitation / Q000628:therapy; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology
D014150:Antipsychotic Agents